A source for healthcare professionals to access the latest data and information on the diagnosis, treatment and management of patients with gut related disorders


Expert opinion

Professor David S. Sanders

Consultant Gastroenterologist and Professor, Royal Hallamshire Hospital and the University of Sheffield, Sheffield, UK

What is the overall benefit for clinicians of an early diagnosis of bile acid diarrhoea?



The benefit is quite significant, both for the physician and for the patient. For physicians, it provides the possibility to avoid numerous diagnostic tests. For example, when investigating patients with unselected irritable bowel syndrome-type symptoms the chances of successfully diagnosing a disease through colonoscopy are very low.

Nowadays, however, if the tauroselcholic (75selenium) acid (SEHCAT) test is performed first (obviously in conjunction with other accepted tests) I believe that bile acid diarrhoea also known as bile acid malabsorption, could be diagnosed in 1 in every 4 patients. For patients, this can drastically change their journey and experience.

Firstly, there will be no delay in the diagnosis, which in some cases can be up to 6 months, and secondly, colonoscopy can sometimes be avoided.

Job number: JB57410GBm Date of Preparation: June 2019

Are you a healthcare professional?

This educational website is developed by GE Healthcare for educational purposes. The information contained within this website is intended for healthcare professionals. By entering this website you are confirming that you are a healthcare professional.

Enter the website

This link opens another website that is not under the review or control of GE Healthcare Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.